Fig. 2From: Who and when should we screen for prostate cancer? Interviews with key opinion leadersMichael Leapman, MD, is currently a urologic oncology fellow at the University of California, San Francisco. He completed his urology residency at the Mount Sinai Hospital in New York. His research interests are in developing novel risk prediction tools in early stage prostate cancerBack to article page